The financial strain of U.S. health care is palpable. One small business owner, in his early 60s, faces a staggering monthly premium of nearly $5,000, consuming more than a quarter of his pre-tax income. In light of these costs, he opted to only cover his wife and two children, prioritizing their well-being while hoping to remain healthy until he qualifies for Medicare. This dilemma is representative of a broader crisis facing many American families.
According to statistics, over 27 million Americans were without health insurance in 2024. The reality is grim for countless individuals who, despite being insured, find themselves burdened by exorbitant deductibles, leaving them unable to afford necessary care. With the average annual premium for employer-sponsored family coverage nearing $27,000, the landscape of health care costs is becoming increasingly unsustainable.
Discussions often point to increasing federal subsidies as a potential relief. While this approach may yield short-term benefits, it falls short of offering a long-term solution. The national debt has surged past $40 trillion, implying that simply shifting costs to the government is not feasible. As it stands, a substantial portion of federal spending—nearly 70%—is allocated to health care and social services, raising critical concerns about sustainability.
Fundamentally, the current system lacks mechanisms to control escalating health spending. To counteract this troubling trend, the proposal for a national office of health care affordability is gaining traction. This entity would be charged with maintaining growth in health care costs at or below the general rate of inflation. Such measures would not only enhance price transparency but also hold entities accountable for annual spending hikes.
By requiring continuous reporting and analysis, this national office could identify and address inefficiencies, thereby instilling a sense of fiscal responsibility across the healthcare sector. When organizations do not meet established cost targets, the office would implement corrective measures, including potential financial penalties for any failure to adhere to these standards.
States like California are already testing such frameworks through its Office of Health Care Affordability (OHCA). This office is pioneering enforceable cost growth targets that apply to the entire health care landscape. Starting in 2028, this ambitious project strives to keep health care expenditure growth in check—targeting a fiscal increment near 3%, aligning more closely with wage growth.
California’s approach further includes a coalition of stakeholders, from health plans and labor unions to large businesses and consumer groups. Their collaborative efforts are aimed at creating a more equitable and transparent health care environment calibrated against the feedback and challenges faced by various players in the system.
However, the model isn't without its detractors. California's hospital association has challenged the effectiveness of these targets, stating that they may not adequately reflect the pressures that providers encounter. These concerns are valid and highlight the necessity for a similar federal framework to tackle nationwide challenges.
Without enforceable cost parameters, groundbreaking therapies, from GLP-1s to gene therapies, risk becoming additional burdens rather than solutions. The ongoing focus on volume rather than value perpetuates inefficiencies, making the exploration of preventative care investments less viable. Until policymakers establish cost certainty, the promise of expanding coverage will remain elusive.
Health care costs have entrenched both Americans and the broader U.S. economy in a perilous situation. Without significant reform and accountability measures, achieving a more efficient and equitable health care system will be exceedingly challenging. It is paramount that the health care sector begins to operate under realistic budget constraints, as so many American households must manage each year.
Paul Markovich serves as President and CEO of Ascendiun, the parent company of Blue Shield of California and its associated entities.